GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) » Definitions » Price-to-Operating-Cash-Flow

Changzhou Qianhong Biopharma Co (SZSE:002550) Price-to-Operating-Cash-Flow : 10.14 (As of May. 10, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Changzhou Qianhong Biopharma Co Price-to-Operating-Cash-Flow?

As of today (2024-05-10), Changzhou Qianhong Biopharma Co's share price is ¥5.76. Changzhou Qianhong Biopharma Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.57. Hence, Changzhou Qianhong Biopharma Co's Price-to-Operating-Cash-Flow Ratio for today is 10.14.

The historical rank and industry rank for Changzhou Qianhong Biopharma Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SZSE:002550' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.22   Med: 38.81   Max: 328.75
Current: 10.16

During the past 13 years, Changzhou Qianhong Biopharma Co's highest Price-to-Operating-Cash-Flow Ratio was 328.75. The lowest was 8.22. And the median was 38.81.

SZSE:002550's Price-to-Operating-Cash-Flow is ranked better than
73.37% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.71 vs SZSE:002550: 10.16

Changzhou Qianhong Biopharma Co's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥0.14. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.57.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 15.90% per year.

During the past 13 years, Changzhou Qianhong Biopharma Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 158.80% per year. The lowest was -55.40% per year. And the median was 15.90% per year.


Changzhou Qianhong Biopharma Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Changzhou Qianhong Biopharma Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changzhou Qianhong Biopharma Co Price-to-Operating-Cash-Flow Chart

Changzhou Qianhong Biopharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.50 16.10 56.16 - 14.31

Changzhou Qianhong Biopharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 117.27 17.76 14.31 8.66

Competitive Comparison of Changzhou Qianhong Biopharma Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Changzhou Qianhong Biopharma Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Changzhou Qianhong Biopharma Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Changzhou Qianhong Biopharma Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Changzhou Qianhong Biopharma Co's Price-to-Operating-Cash-Flow falls into.



Changzhou Qianhong Biopharma Co Price-to-Operating-Cash-Flow Calculation

Changzhou Qianhong Biopharma Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=5.76/0.568
=10.14

Changzhou Qianhong Biopharma Co's Share Price of today is ¥5.76.
Changzhou Qianhong Biopharma Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.57.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Changzhou Qianhong Biopharma Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Changzhou Qianhong Biopharma Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Changzhou Qianhong Biopharma Co (SZSE:002550) Business Description

Traded in Other Exchanges
N/A
Address
Number 90 Changjiang Middle Road, Xinbei distract, Jiangsu Province, Changzhou, CHN, 213022
Changzhou Qianhong Biopharma Co Ltd engages in the research and development, production, and sale of biopharmaceutical products with the focus on polysaccharides and enzymes in China. The company provides various products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; and kallidinogenase kallikrein and heparinoid.

Changzhou Qianhong Biopharma Co (SZSE:002550) Headlines

No Headlines